Loading
Life sciences · Journal article
Annual Review of Physiology · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Flow disturbances in the smallest blood vessels of the brain, the capillaries, have long been considered a potential cause of brain dysfunction. However, owing to the technological challenge of studying blood flow in three-dimensional capillary networks, elucidating the incidence, causes, and consequences of capillary obstructions has been difficult. Advances in optical microscopes for in vivo imaging, primarily high-spatiotemporal-resolution optical coherence tomography and two-photon microscopy, have recently enabled detailed studies of these capillary stalling events in both healthy and diseased mice. In this review, we describe these imaging approaches to quantify capillary stalling, identifying strengths and weaknesses of different methods. We then review recent findings on the incidence, molecular and cellular causes, and physiological and neurological consequences of capillary stalling across multiple mouse models of brain disease, including Alzheimer's disease, stroke, and traumatic brain injury. We conclude by suggesting necessary next steps in instrumentation and analysis for studying capillary stalling, as well as how to address key unanswered questions about underlying mechanisms for capillary stalling in the brain and how this phenomenon may impact disease progression and cognitive function.